Medpace Holdings Reports Q1 Earnings, Shares Move Lower

Medpace Holdings Inc MEDP reported first-quarter financial results after market close on Monday. Here’s a look at the key metrics from the quarter . Q1 Revenue: $558.

57 million, versus estimates of $527.15 million Q1 EPS: $3.67, versus estimates of $3.



06 Total revenue was up 9.3% on a year-over-year basis. New business awards totaled $500 million in the quarter, down 18.

8% year-over-year. The company ended the period with a backlog of approximately $2.85 billion, down 2.

1% year-over-year. Medpace generated $125.8 million in cash flow from operations during the quarter.

The company said it repurchased approximately 1.19 million shares for $389.8 million in the first quarter.

Medpace’s board also authorized a $1 billion increase to the company’s buyback, bringing the total authorization up to approximately $1.34 billion. The company ended the quarter with $441.

4 million in cash and cash equivalents. Outlook: Medpace expects full-year 2025 revenue to be between $2.14 billion and $2.

24 billion versus estimates of $2.15 billion. The company anticipates full-year earnings of $12.

26 to $13.04 per share versus estimates of $12.27 per share.

Medpace executives will further discuss the quarter on a call with investors and analysts Tuesday morning at 9 a.m. ET.

MEDP Price Action: Medpace shares were down 9.34% after-hours, trading at $262 at the time of publication Monday, according to Benzinga Pro . Check This Out: • Calix Stock Jumps On Strong Q1 Earnings, $100 Million Buyback Increase Photo: mariakray /Shutterstock.

Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock – anytime. © 2025 Benzinga.com.

Benzinga does not provide investment advice. All rights reserved..